[1. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686-697. doi:10.1161/CIRCULATIONAHA.106.613596.10.1161/CIRCULATIONAHA.106.61359618250279]Search in Google Scholar
[2. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998-3002. doi: 10.1161/01.CIR.0000075927.67673.F2.10.1161/01.CIR.0000075927.67673.F212821585]Search in Google Scholar
[3. Khalid L, Dhakam S. A Review of Cardiogenic Shock in Acute Myocardial Infarction. Current Cardiology Reviews. 2008;4:34-40. doi: 10.2174/157340308783565456.10.2174/157340308783565456277458319924275]Search in Google Scholar
[4. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625-34. doi: 10.1056/NEJM199908263410901.10.1056/NEJM19990826341090110460813]Search in Google Scholar
[5. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007; 297:1892-1900. doi:10.1001/jama.297.17.1892.10.1001/jama.297.17.189217473299]Search in Google Scholar
[6. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty Year Trends (1975-2005) in the Magnitude, Management, and Hospital Death Rates Associated With Cardiogenic Shock in Patients with Acute Myocardial Infarction: A Population-Based Perspective. Circulation. 2009;119:1211-1219. doi:10.1161/CIRCULATIONAHA.108.814947.10.1161/CIRCULATIONAHA.108.814947273083219237658]Search in Google Scholar
[7. Babaev A, Frederick PD, Pasta DJ, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005; 294:448-454. doi: 10.1001/jama.294.4.448.10.1001/jama.294.4.44816046651]Search in Google Scholar
[8. TRIUMPH Investigators, Alexander JH, Reynolds HR, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007;297:1657-1666. doi: 10.1001/jama.297.15.joc70035.10.1001/jama.297.15.joc7003517387132]Search in Google Scholar
[9. Werdan K, Ruß M, Buerke M, et al. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int. 2012;109:343-51. doi: 10.3238/arztebl.2012.0343.10.3238/arztebl.2012.0343336452822675405]Search in Google Scholar
[10. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686-697. doi: 10.1161/CIRCULATIONAHA.106.613596.10.1161/CIRCULATIONAHA.106.613596]Search in Google Scholar
[11. Bartling B, Milting H, Schumann H, et al. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation. 1999;100:216-223. https://doi.org/10.1161/01.CIR.100.suppl_2.II-216.10.1161/01.CIR.100.suppl_2.II-216]Search in Google Scholar
[12. Li YY, Feng Y, McTiernan CF, et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 2001;104:1147-1152.10.1161/hc3501.09521511535571]Search in Google Scholar
[13. Delgado R 3rd, Radovancevic B, Massin EK, Frazier OH, Benedict C. Neurohormonal changes after implantation of a left ventricular assist system. ASAIO J. 1998;44:299-302.10.1097/00002480-199807000-000119682956]Search in Google Scholar
[14. Shah NR, Bieniarz MC, Basra SS, et al. Serum biomarkers in severe refractory cardiogenic shock. JACC Heart Fail. 2013;1:200-6. doi: 10.1016/j.jchf.2013.03.002.10.1016/j.jchf.2013.03.00224621870]Search in Google Scholar
[15. Chiotoroiu A, Buicu F, Benedek T. Recent advances in biomarker discovery – from serum to imaging-based biomarkers for a complex assessment of heart failure patients. Journal of Interdisciplinary Medicine. 2016;1:125-130. doi: 10.1515/jim-2016-0045.10.1515/jim-2016-0045]Search in Google Scholar
[16. Meredith AJ, Dai DLY, Chen V, et al. Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope-dependent acute heart failure. Esc Heart Failure. 2016;3:86-96. doi:10.1002/ehf2.12076.10.1002/ehf2.12076506315827774271]Search in Google Scholar
[17. Duma RJ, Siegel AL. Serum creatinine phosphokinase in acute myocardial infarction: diagnostic value. Arch Intern Med. 1965;115:443-51.10.1001/archinte.1965.0386016006901114274140]Search in Google Scholar
[18. Pierce GF, Jaffe AS. Increased creatine kinase MB in the absence of acute myocardial infarction. Clin Chem. 1986;32:2044-51.10.1093/clinchem/32.11.2044]Search in Google Scholar
[19. Al-Hadi HA, Fox KA. Cardiac Markers in the Early Diagnosis and Management of Patients with Acute Coronary Syndrome. Sultan Qaboos University Medical Journal. 2009;9:231-246.]Search in Google Scholar
[20. Saenger AK, Jaffe AS. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Med Clin North Am. 2007;91:657-681. doi: 10.1016/j.mcna.2007.04.001.10.1016/j.mcna.2007.04.00117640541]Search in Google Scholar
[21. Irvin RG, Cobb FR, Roe CR. Acute myocardial infarction and MB creatine phosphokinase. Relationship between onset of symptoms of infarction and appearance and disappearance of enzyme. Arch Intern Med. 1980;140:329-334. doi:10.1001/archinte.1980.00330150043014.10.1001/archinte.1980.00330150043014]Search in Google Scholar
[22. Gibler WB, Young GP, Hedges JR et al. Acute myocardial infarction in chest pain patients with non-diagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group. Ann Emerg Med. 1992;21:504-512.]Search in Google Scholar
[23. Daubert MA, Jeremias A. The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag. 2010;6:691-699.]Search in Google Scholar
[24. del Val Martin D, Sanmartin Fernandez MS, Zamorano Gomez JL. Biomarkers in acute coronary syndrome. IJC Metabolic & Endocrine. 2015;8:20-23. https://doi.org/10.1016/j.ijcme.2015.04.00310.1016/j.ijcme.2015.04.003]Search in Google Scholar
[25. Tucker JF, Collins RA, Anderson AJ, Hauser J, Kalas J, Apple FS. Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction. Acad Emerg Med. 1997;4:13-21.10.1111/j.1553-2712.1997.tb03637.x9110006]Search in Google Scholar
[26. Vaughan L. Biomarkers in acute medicine. Medicine. 2013;41:136-141. doi: http://dx.doi.org/10.1016/j.mpmed.2013.01.001.10.1016/j.mpmed.2013.01.001]Search in Google Scholar
[27. Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag. 2011;7:597-603. doi:10.2147/VHRM.S24509.10.2147/VHRM.S24509321242522102783]Search in Google Scholar
[28. Gunnewiek JM, Van Der Hoeven JG. Cardiac troponin elevations among critically ill patients. Curr Opin Crit Care. 2004;10:342-346.10.1097/01.ccx.0000135514.20538.4415385749]Search in Google Scholar
[29. Peacock WF 4th, De Marco T, Fonarow GC, et al. Cardiac Troponin and Outcome in Acute Heart Failure. N Engl J Med. 2008;358:2117-2126. doi: 10.1056/NEJMoa0706824.10.1056/NEJMoa070682418480204]Search in Google Scholar
[30. Sato Y, Yamada T, Taniguchi T, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 2001;103:369-74.10.1161/01.CIR.103.3.36911157687]Search in Google Scholar
[31. Pascual-Figal DA, Manzano-Fernandez S, Boronat M, et al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail. 2011;13:718-725. doi: 10.1093/eurjhf/hfr047.10.1093/eurjhf/hfr04721551163]Search in Google Scholar
[32. Jolly SS, Shenkman H, Brieger D, et al. Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events. Heart. 2011;97:197-202. doi: 10.1136/hrt.2010.195511.10.1136/hrt.2010.19551121076124]Search in Google Scholar
[33. Iqbal MP, Kazmi KA, Mehboobali N, Rahbar A. Myoglobin – a marker of reperfusion and a prognostic indicator in patients with acute myocardial infarction. Clin Cardiol. 2004;27:144-50.10.1002/clc.4960270309665461615049381]Search in Google Scholar
[34. Alhadi HA, Fox KA. Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM. 2004;97:187-198.10.1093/qjmed/hch03715028848]Search in Google Scholar
[35. Colli A, Josa M, Pomar JL, Mestres CA, Gherli T. Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today? Cardiology. 2007;108:4-10. doi: 10.1159/000095594.10.1159/00009559416960442]Search in Google Scholar
[36. Alansari SE, Croal BL. Diagnostic value of heart fatty acid binding protein and myoglobin in patients admitted with chest pain. Ann Clin Biochem. 2004;41:391-396. doi: 10.1258/0004563041731565.10.1258/000456304173156515333191]Search in Google Scholar
[37. Ilva T, Lund J, Porela P, et al. Early markers of myocardial injury: cTnI is enough. Clin Chim Acta. 2009;400:82-85. doi: 10.1016/j.cca.2008.10.005.10.1016/j.cca.2008.10.00518992232]Search in Google Scholar
[38. Manzano-Fernandez S, Januzzi JL, Pastor-Perez FJ, et al. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure. Cardiology. 2012;122:158-166. doi: 10.1159/000338800.10.1159/00033880022832599]Search in Google Scholar
[39. Caselli C, D'Amico A, Ragusa R, et al. IL-33/ST2 pathway and classical cytokines in end-stage heart failure patients submitted to left ventricular assist device support: a paradoxic role for inflammatory mediators? Mediators Inflamm. 2013;2013:498703. doi: 10.1155/2013/498703.10.1155/2013/498703387244524385685]Search in Google Scholar
[40. Meredith AJ, Dai DLY, Chen V, et al. Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope-dependent acute heart failure. Esc Heart Failure. 2016;3:86-96. doi:10.1002/ehf2.12076.10.1002/ehf2.12076506315827774271]Search in Google Scholar
[41. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.10.1161/01.CIR.90.1.1958025996]Search in Google Scholar
[42. Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation. 2003;107:2786-2792. doi: 10.1161/01.CIR.0000070953.76250.B9.10.1161/01.CIR.0000070953.76250.B912771003]Search in Google Scholar
[43. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-1021. doi: 10.1056/NEJMoa011053.10.1056/NEJMoa01105311586953]Search in Google Scholar
[44. Khan SQ, Dhillon OS, O’Brien RJ, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007;115:2103-2110. doi: 10.1161/CIRCULATIONAHA.106.685503.10.1161/CIRCULATIONAHA.106.68550317420344]Search in Google Scholar
[45. Reichlin T, HochholzerW, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol. 2009;54:60-68. doi:10.1016/j.jacc.2009.01.076.10.1016/j.jacc.2009.01.07619555842]Search in Google Scholar
[46. Shpektor A. Cardiogenic shock: the role of inflammation. Acute Card Care. 2010;12:115-118. doi: 10.3109/17482941.2010.523705.10.3109/17482941.2010.52370521039083]Search in Google Scholar
[47. Kohsaka S, Menon V, Lowe AM, et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165:1643-1650. doi: 10.1001/archinte.165.14.1643.10.1001/archinte.165.14.164316043684]Search in Google Scholar
[48. Pudil R, Krejsek J, Pidrman V, Gregor J, Tichy M, Bures J. Inflammatory response to acute myocardial infarction complicated by cardiogenic shock. Acta Medica. 2001;44:149-151.]Search in Google Scholar
[49. Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K. Plasma concentrations of interlukin-6, organ failure, vasopressor support, and successful revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med. 2006;34:2035-2042. doi: 10.1097/01.CCM.0000228919.33620.D9.10.1097/01.CCM.0000228919.33620.D916775569]Search in Google Scholar
[50. Theroux P, Armstrong PW, Mahaffey KW et al. Prognostic significance of blood markers of inflammation in patients with ST-elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: A substudy of the COMMA trial. Eur Heart J. 2005:26;1964-1970. doi:10.1093/eurheartj/ehi292.10.1093/eurheartj/ehi29215872036]Search in Google Scholar
[51. Mueller C, Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 2002;105:1412-1415.10.1161/01.CIR.0000012625.02748.6211914246]Search in Google Scholar
[52. Schiele F, Meneveau N, Seronde MF, et al. C-reactive proteinimproves risk prediction in patients with acute coronary syndromes. Eur Heart J. 2010;31:290-297. doi:10.1093/eurheartj/ehp273.10.1093/eurheartj/ehp27319578164]Search in Google Scholar
[53. Meijers WC, van der Velde AR, de Boer RA. The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure. Expert Rev Mol Diagn. 2014;14:257-266. doi: 10.1586/14737159.2014.892421.10.1586/14737159.2014.89242124606321]Search in Google Scholar
[54. Giannitsis E, Katus HA. Troponins and high-sensitivity troponins as markers of necrosis in CAD and heart failure. Herz. 2009;34:600-606. doi: 10.1007/s00059-009-3306-6.10.1007/s00059-009-3306-620024639]Search in Google Scholar
[55. Daniels LB, Bayes-Genis A. Using ST2 in cardiovascular patients: a review. Future Cardiol. 2014;10:525-539. doi: 10.2217/fca.14.36.10.2217/fca.14.3625301315]Search in Google Scholar
[56. De Berardinis B, Gaggin HK, Magrini L, et al. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. Clin Chem Lab Med. 2014;53:613-621. http://dx.doi.org/10.1515/cclm-2014-0191.10.1515/cclm-2014-019125473804]Search in Google Scholar
[57. Anand IS, Latini R, Florea VG, et al. C-Reactive Protein in Heart Failure Prognostic Value and the Effect of Valsartan. Circulation. 2005;112:1428-1434. doi: 10.1161/CIRCULATIONAHA.104.508465.10.1161/CIRCULATIONAHA.104.50846516129801]Search in Google Scholar
[58. Ribeiro DRP, Ramos AM, Vieira PL, et al. High-Sensitivity C-Reactive Protein as a Predictor of Cardiovascular Events after ST-Elevation Myocardial Infarction. Arquivos Brasileiros de Cardiologia. 2014;103:69-75. doi:10.5935/abc.20140086.10.5935/abc.20140086412676325120085]Search in Google Scholar
[59. Yip HK, Hang CL, Fang CY, et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest. 2005;127:803-808. doi: 10.1378/chest.127.3.803.10.1378/chest.127.3.80315764760]Search in Google Scholar
[60. Magdalen R, Hertz I, Merlon H, Weiner P, Mohammedi I, Robert D. The relation between preprocedural C-reactive protein levels and early and late complications in patients with acute myocardial infarction undergoing interventional coronary angioplasty. Clin Cardiol. 2004;27:163-168.10.1002/clc.4960270314665448215049386]Search in Google Scholar
[61. Karpiński L, Płaksej R, Kosmala W, Witkowska M. Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol Pol. 2008;66:1279-1285.]Search in Google Scholar
[62. Matsubara J, Sugiyama S, Nozaki T, et al. Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction. J Am Heart Assoc. 2014;3:1-11. doi:10.1161/JAHA.114.000928.10.1161/JAHA.114.000928431037825012287]Search in Google Scholar
[63. Guo R, Li Y, Wen J, Li W, Xu Y. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention. Cardiology. 2014;129:178-188. doi: 10.1159/000364996.10.1159/00036499625323314]Search in Google Scholar
[64. Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004;110:2349-2354. doi: 10.1161/01.CIR.0000145167.30987.2E.10.1161/01.CIR.0000145167.30987.2E15477419]Search in Google Scholar
[65. Mallick A, Lanuzzi JL. Biomarkers in acute heart failure. Rev Esp Cardiol. 2015;68:514-525. doi: 10.1016/j.rec.2015.02.009.10.1016/j.rec.2015.02.00925911167]Search in Google Scholar
[66. Bayes-Genis A, Ordonez-Llanos J. Multiple biomarker strategies for risk stratification in heart failure. Clin Chim Acta. 2015;443:120-125. doi: 10.1016/j.cca.2014.10.023.10.1016/j.cca.2014.10.02325451945]Search in Google Scholar
[67. De Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. Am Heart J. 2012;163:821-828. doi: 10.1016/j.ahj.2012.03.004.10.1016/j.ahj.2012.03.00422607860]Search in Google Scholar
[68. Maisel AS, Mueller C, Fitzgerald R, et al. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail. 2011;13:846-851. doi: 10.1093/eurjhf/hfr087.10.1093/eurjhf/hfr087314383221791540]Search in Google Scholar
[69. Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng. 2005;7:223-253. doi:10.1146/annurev.bioeng.7.060804.100453.10.1146/annurev.bioeng.7.060804.10045316004571]Search in Google Scholar
[70. van Kimmenade RR, Januzzi JL Jr, Ellinor PT, et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol. 2006;48:1217-1224. doi: 10.1016/j.jacc.2006.03.061.10.1016/j.jacc.2006.03.06116979009]Search in Google Scholar
[71. Bayes-Genis A, Ordonez-Llanos J. Multiple biomarker strategies for risk stratification in heart failure. Clin Chim Acta. 2015;443:120-125. doi: 10.1016/j.cca.2014.10.023.10.1016/j.cca.2014.10.023]Search in Google Scholar
[72. Ky B, French B, Levy WC, et al. Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail. 2012;5:183-190. doi: 10.1161/CIRCHEARTFAILURE.111.965020.10.1161/CIRCHEARTFAILURE.111.965020338748722361079]Search in Google Scholar
[73. Daniels LB, Bayes-Genis A. Using ST2 in cardiovascular patients: a review. Future Cardiol. 2014;10:525-539. doi: 10.2217/fca.14.36.10.2217/fca.14.3625301315]Search in Google Scholar
[74. de Boer RA, Lok DJ, Jaarsma T, et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 2011;43:60-68. doi: 10.3109/07853890.2010.538080.10.3109/07853890.2010.538080302857321189092]Search in Google Scholar
[75. Singh RB, Dandekar SP, Elimban V, Gupta SK, Dhalla NS. Role of proteases in the pathophysiology of cardiac disease. Mol Cell Biochem. 2004;263:241-256.10.1023/B:MCBI.0000041865.63445.40]Search in Google Scholar
[76. Ali MA, Schulz R. Activation of MMP-2 as a key event in oxidative stress injury to the heart. Front Biosci (Landmark Ed). 2009;14:699-716.]Search in Google Scholar
[77. Ahmed SH, Clark LL, Pennington WR, et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix, composition and structural, functional and clinical manifestations of hypertensive heart disease. Circulation 2006;113:2089-2096. doi: 10.1161/CIRCULATIONAHA.105.573865.10.1161/CIRCULATIONAHA.105.573865]Search in Google Scholar
[78. Krum H, Elsik M, Schneider HG, et al. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circ Heart Fail. 2011:4:561-568. doi:10.1161/CIRCHEARTFAILURE.110.960716.10.1161/CIRCHEARTFAILURE.110.960716]Search in Google Scholar
[79. Rao PK, Toyama Y, Chiang HR et al. Loss of cardiac microRNAmediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res. 2009;105:585-594. doi:10.1161/CIRCULATIONAHA.105.573865.10.1161/CIRCULATIONAHA.105.573865]Search in Google Scholar
[80. Wang Y, Pan X, Fan Y, et al. Dysregulated expression of microRNAs and mRNAs in myocardial infarction. Am J Transl Res. 2015;7:2291-2304.]Search in Google Scholar
[81. Stanton LW, Garrard LJ, Damm D, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res. 2000;86:939-945.10.1161/01.RES.86.9.939]Search in Google Scholar
[82. Kiliszek M, Burzynska B, Michalak M, et al. Altered gene expression pattern in peripheral blood mononuclear cells in patients with acute myocardial infarction. PLoS One. 2012;7:e50054. doi: 10.1371/journal.pone.0050054.10.1371/journal.pone.0050054]Search in Google Scholar
[83. Drew BJ, Califf RM, Funk M, et al. Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical Care Nurses. Circulation. 2004;110:2721-2746. doi: 10.1161/01.CIR.0000145144.56673.59.10.1161/01.CIR.0000145144.56673.59]Search in Google Scholar
[84. Stevenson RN, Marchant BG, Ranjadayalan K, Uthayakumar S, Timmis AD. Holter ST monitoring early after acute myocardial infarction: mechanisms of ischaemia in patients treated by thrombolysis. Br Heart J. 1993;70:433-437.10.1136/hrt.70.5.433]Search in Google Scholar
[85. Johanson P, Jernberg T, Gunnarsson G, Lindahl B, Wallentin L, Dellborg M. Prognostic value of ST segment resolution when and what to measure. Eur Heart J. 2003;24:337-345. doi: https://doi.org/10.1016/S0195-668X(02)00739-X.10.1016/S0195-668X(02)00739-X]Search in Google Scholar
[86. Flanders SA. ST Segment Monitoring: Putting Standards Into Practice. AACN Adv Crit Care. 2007;18:275-284.10.1097/01.AACN.0000284428.63460.52]Search in Google Scholar
[87. Leung JM, Voskanian A, Bellows AM. Automated electrocardiograph ST segment trending monitors: accuracy in detecting myocardial ischemia. Anesth Analg. 1998;87:4-10.]Search in Google Scholar
[88. Shanewise J. How to Reliably Detect Ischemia in the Intensive Care Unit and Operating Room. Semin Cardiothorac Vasc Anesth. 2006;10:101-109. doi: 10.1177/108925320601000117.10.1177/10892532060100011716703242]Search in Google Scholar
[89. Opincariu D, Chitu M, Rat N, Benedek I. Integrated ST segment elevation scores and in-hospital mortality in STEMI patients undergoing primary PCI. Journal of Cardiovascular Emergencies. 2016;2:114-121. doi: 10.1515/jce-2016-0018.10.1515/jce-2016-0018]Search in Google Scholar
[90. Ikossi DG, Knudson MM, Morabito DJ, et al. Continuous muscle tissue oxygenation in critically injured patients: a prospective observational study. J Trauma. 2006;61:780-790. doi: 10.1097/01.ta.0000239500.71419.58.10.1097/01.ta.0000239500.71419.5817033541]Search in Google Scholar
[91. Nicks BA, Campos KM, Bozeman WP. Association of low noninvasive near-infrared spectroscopic measurements during initial trauma resuscitation with future development of multiple organ dysfunction. World J Emerg Med. 2015;6:105-110. doi: 10.5847/wjem.j.1920-8642.2015.02.004.10.5847/wjem.j.1920-8642.2015.02.004445846926056540]Search in Google Scholar
[92. Miner J, Nelson R, Hayden L. The effect of near infrared spectroscopy monitoring on the treatment of patients presenting to the emergency department in shock. Crit Care Med. 2010;38:S861.]Search in Google Scholar
[93. Lima A, van Bommel J, Jansen TC, Ince C, Bakker J. Low tissue oxygen saturation at the end of early goal-directed therapy is associated with worse outcome in critically ill patients. Crit Care. 2009;13(Suppl5):S13. doi: 10.1186/cc8011.10.1186/cc8011278611519951385]Search in Google Scholar
[94. Mariscalo G, Musumeci F. Fluid management in the cardiothoracic intensive care unit: diuresis – diuretics and hemofiltration. Curr Opin Anaesthesiol. 2014;27:133-139. doi: 10.1097/ACO.0000000000000055.10.1097/ACO.000000000000005524514030]Search in Google Scholar
[95. Jakovljevic DG, Moore S, Hallsworth K, Fattakhova G, Thoma C, Trenell MI. Comparison of cardiac output determined by bioimpedance and bioreactance methods at rest and during exercise. J Clin Monit Comput. 2012;26:63-68. doi: 10.1007/s10877-012-9334-4.10.1007/s10877-012-9334-422234400]Search in Google Scholar
[96. Laupland KB, Shahpori R, Kirkpatrick AW, et al. Occurrence and outcome of fever in critically ill adults. Crit Care Med. 2008;36:1531. doi: 10.1097/CCM.0b013e318170efd3.10.1097/CCM.0b013e318170efd318434882]Search in Google Scholar
[97. Ryan M, Levy MM. Clinical review: fever in intensive care unit patients. Crit Care. 2003;7:221-225.10.1186/cc187927066712793871]Search in Google Scholar
[98. Niven DJ, Léger C, Stelfox HT, Laupland KB. Fever in the critically ill: a review of epidemiology, immunology, and management. J Intensive Care Med. 2012;27:290-297. doi: 10.1177/0885066611402463.10.1177/088506661140246321441283]Search in Google Scholar
[99. Niven DJ, Gaudet JE, Laupland KB, Mrklas KJ, Roberts DJ, Stelfox HT. Accuracy of Peripheral Thermometers for Estimating Temperature: A Systematic Review and Metaanalysis. Ann Intern Med. 2015;163:768-777. doi: 10.7326/M15-1150.10.7326/M15-115026571241]Search in Google Scholar
[100. Jefferies S, Weatherall M, Young P, Beasley R. A systematic review of the accuracy of peripheral thermometry in estimating core temperatures among febrile critically ill patients. Crit Care Resusc. 2011;13:194-199.]Search in Google Scholar
[101. Young PJ, Saxena M, Beasley R, et al. Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med. 2012. doi: 10.1007/s00134-012-2478-3.10.1007/s00134-012-2478-322290072]Search in Google Scholar
[102. Jeremy S. Bock and Stephen S. Gottlieb. Cardiorenal Syndrome. Circulation. 2010;121:2592-2600. https://doi.org/10.1161/CIRCULATIONAHA.109.886473.10.1161/CIRCULATIONAHA.109.88647320547939]Search in Google Scholar
[103. Md Ralib A, Pickering JW, Shaw GM, Endre ZH. The urine output definition of acute kidney injury is too liberal. Critical Care. 2013;17:R112. doi:10.1186/cc12784.10.1186/cc12784405634923787055]Search in Google Scholar
[104. Prowle JR, Liu YL, Licari E, et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care. 2011;17:R172. doi: 10.1186/cc10318.10.1186/cc10318338761421771324]Search in Google Scholar
[105. Macedo E, Malhotra R, Bouchard J, Wynn SK, Mehta RL. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int. 2011;80:760-767. doi: 10.1038/ki.2011.150.10.1038/ki.2011.15021716258]Search in Google Scholar
[106. Uchino S, Kellum JA, Bellomo R, et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813-818. doi: 10.1001/jama.294.7.813.10.1001/jama.294.7.81316106006]Search in Google Scholar
[107. Antonelli M, Levy M, Andrews PJ, et al. Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006. Intensive Care Med. 2007;33:575-590. doi: 10.1007/s00134-007-0531-4.10.1007/s00134-007-0531-417285286]Search in Google Scholar
[108. McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol. 2006;98:5K-13K.10.1016/j.amjcard.2006.01.01916949375]Search in Google Scholar
[109. Mohammed NMA, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14:106-116. doi:10.4103/1995-705X.125926.10.4103/1995-705X.125926396962624696755]Search in Google Scholar
[110. Truijen J, van Lieshout JJ, Wesselink WA, Westerhof BE. Noninvasive continuous hemodynamic monitoring. J Clin Monit Comput. 2012;26:267-278. doi:10.1007/s10877-012-9375-8.10.1007/s10877-012-9375-8339135922695821]Search in Google Scholar
[111. Ameloot K, Palmers PJ, Malbrain ML. The accuracy of noninvasive cardiac output and pressure measurements with finger cuff: a concise review. Curr Opin Crit Care. 2015;21:232-239. doi: 10.1097/MCC.0000000000000198.10.1097/MCC.000000000000019825922896]Search in Google Scholar
[112. Martina JR, Westerhof BE, van Goudoever J, et al. Noninvasive continuous arterial blood pressure monitoring with Nexfin®. Anesthesiology. 2012;116:1092-1103. doi: 10.1097/ALN.0b013e31824f94ed.10.1097/ALN.0b013e31824f94ed22415387]Search in Google Scholar
[113. Kim SH, Lilot M, Sidhu KS, et al. Accuracy and precision of continuous noninvasive arterial pressure monitoring compared with invasive arterial pressure: a systematic review and meta-analysis. Anesthesiology. 2014;120:1080-1097. doi: 10.1097/ALN.0000000000000226.10.1097/ALN.000000000000022624637618]Search in Google Scholar
[114. Keren H, Burkhoff D, Squara P. Evaluation of a noninvasive continuous cardiac output monitoring system based on thoracic bioreactance. Am J Physiol Heart Circ Physiol. 2007;293:H583-H589. doi: 10.1152/ajpheart.00195.2007.10.1152/ajpheart.00195.200717384132]Search in Google Scholar
[115. van Lieshout JJ, Toska K, van Lieshout EJ, Eriksen M, Walløe L, Wesseling KH. Beat-to-beat noninvasive stroke volume from arterial pressure and Doppler ultrasound. Eur J Appl Physiol. 2003;90:131-137.10.1007/s00421-003-0901-812851826]Search in Google Scholar
[116. Engore M, Barbee D. Comparison of Cardiac Output Determined by Bioimpedance, Thermodilution, and the Fick Method. Am J Crit Care. 2005;14:40-45.10.4037/ajcc2005.14.1.40]Search in Google Scholar
[117. Ball TR, Culp BC, Patel V, et al. Comparation of the endotracheal cardiac output monitor to thermodilution in cardiac surgery patients. J Cardiothorac Vasc. 2010;24:762-766. doi: 10.1053/j.jvca.2010.04.008.10.1053/j.jvca.2010.04.00820674392]Search in Google Scholar
[118. Babbs CF. Noninvasive measurement of cardiac stroke volume using pulse wave velocity and aortic dimensions: a simulation study. BioMedical Engineering OnLine. 2014;13:137. doi:10.1186/1475-925X-13-137.10.1186/1475-925X-13-137427135725238910]Search in Google Scholar
[119. Sakka SG, Kozieras J, Thuemer O, van Hout N. Measurement of cardiac output: a comparison between transpulmonary thermodilution and uncalibrated pulse contour analysis. Br J Anaesth. 2007;99:337-342.10.1093/bja/aem17717611251]Search in Google Scholar
[120. Oren-Grinberg A. The PiCCO Monitor. Int Anesthesiol Clin. 2010;48:57-85. doi: 10.1097/AIA.0b013e3181c3dc11.10.1097/AIA.0b013e3181c3dc1120065727]Search in Google Scholar
[121. Young BP, Low LL. Noninvasive monitoring cardiac output using partial CO(2) rebreathing. Crit Care Clin. 2010;26:383-392. doi: 10.1016/j.ccc.2009.12.002.10.1016/j.ccc.2009.12.00220381727]Search in Google Scholar
[122. Cholley BP, Vieillard-Baron A, Mebazaa A. Echocardiography in the ICU: time for widespread use! Intensive Care Med. 2006;32:9-10. doi: 10.1007/s00134-005-2833-8.10.1007/s00134-005-2833-816292627]Search in Google Scholar
[123. Wilansky S. Echocardiography in the Assessment of Complications of Myocardial Infarction. Tex Heart Inst J. 1991;18:237-242.]Search in Google Scholar
[124. Esmaeilzadeh M, Parsaee M, Maleki M. The Role of Echocardiography in Coronary Artery Disease and Acute Myocardial Infarction. J Tehran Heart Cent. 2013;8:1-13.]Search in Google Scholar
[125. Bródka J, Tułecki Ł, Ciurysek M, Gburek T. Thermodilution vs transesophageal echocardiography for cardiac output measurement in patients with good left ventricle function. Anestezjol Intens Ter. 2010;42:15-18.]Search in Google Scholar
[126. Perrino AC Jr, Harris SN, Luther MA. Intraoperative determination of cardiac output using multiplane transesophageal echocardiography: a comparison to thermodilution. Anesthesiology. 1998;89:350-357.10.1097/00000542-199808000-000109710392]Search in Google Scholar
[127. Mehta Y, Arora D. Newer methods of cardiac output monitoring. World J Cardiol. 2014;6:1022-1029. doi:10.4330/wjc.v6.i9.102210.4330/wjc.v6.i9.1022417679325276302]Search in Google Scholar
[128. Laupland KB, Bands CJ. Utility of esophageal Doppler as a minimally invasive hemodynamic monitor: a review. Can J Anaesth. 2002;49:393-401. doi: 10.1007/BF03017329.10.1007/BF0301732911927480]Search in Google Scholar
[129. Sharma J, Bhise M, Singh A, Mehta Y, Trehan N. Hemodynamic measurements after cardiac surgery: transesophageal Doppler versus pulmonary artery catheter. J Cardiothorac Vasc Anesth. 2005;19:746-750.10.1053/j.jvca.2004.11.03816326299]Search in Google Scholar
[130. Camporata L, Beale R. Pitfalls in haemodynamic monitoring based on the arterial pressure waveform. Crit Care. 2010;14:124. doi: 10.1186/cc8845.10.1186/cc8845288710020236463]Search in Google Scholar
[131. Thom O, Taylor DM, Wolfe RE. Comparation of a suprasternal cardiac output monitor (USCOM) with the pulmonary artery catheter. Br J Anaesth. 2009;103:800-804. doi: 10.1093/bja/aep296.10.1093/bja/aep29619864307]Search in Google Scholar
[132. Pulmonary Artery Consensus Conference: consensus statement. Crit Care Med. 1997;25:910-925.10.1097/00003246-199706000-000069201042]Search in Google Scholar
[133. Bishop MH. Invasive monitoring in trauma and other critical illness. Current Opinion in Critical Care 1995;3:206.10.1097/00075198-199506000-00009]Search in Google Scholar
[134. Magder S. Invasive hemodynamic monitoring. Crit Care Clin. 2015;31:67-87. doi: 10.1016/j.ccc.2014.08.004.10.1016/j.ccc.2014.08.00425435479]Search in Google Scholar
[135. De Backer D. Is there a role for invasive hemodynamic monitoring in acute heart failure management? Curr Heart Fail Rep. 2015;12:197-204. doi: 10.1007/s11897-015-0256-6.10.1007/s11897-015-0256-625721355]Search in Google Scholar
[136. Runciman WB, Ilsley AH, Roberts JG. An evaluation of thermodilution cardiac output measurement using the Swan-Ganz catheter. Anaesth Intensive Care. 1981;9:208-220.10.1177/0310057X81009003027025698]Search in Google Scholar
[137. Ameloot K, Meex I, Genbrugge C, et al. Accuracy of continuous thermodilution cardiac output monitoring by pulmonary artery catheter during therapeutic hypothermia in postcardiac arrest patients. Resuscitation. 2014;85:1263-1268. doi: 10.1016/j.resuscitation.2014.06.025.10.1016/j.resuscitation.2014.06.02525008135]Search in Google Scholar
[138. Mebazaa A, Gheoghiade M, Piña IL, et al. Practical recommendations for prehospital and early in hospital management of patients presenting with acute heart failure SNVSndromes. Crit Care Med. 2008;36(1 Suppl):S129-S139. doi: 10.1097/01.CCM.0000296274.51933.4C.10.1097/01.CCM.0000296274.51933.4C18158472]Search in Google Scholar
[139. Filipescu D, Tomescu D, Droc G, et al. Recomandări pentru monitorizarea hemodinamică în soc. In: Sandesc D, Bedreag O (eds), Recomandări si protocoale în anestezie, terapie intensivă și medicină de urgentă. Timișoara: Ed Mirton, 2009; p. 541-570.]Search in Google Scholar
[140. Weed HG. Pulmonary “capillary” wedge pressure not the pressure in the pulmonary capillaries. Chest. 1991;100:1138-1140.10.1378/chest.100.4.11381914574]Search in Google Scholar
[141. Ryan JJ, Rich JD, Thiruvoipati T, Swamy R, Kim GH, Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012;163:589-594. doi: 10.1016/j.ahj.2012.01.024.10.1016/j.ahj.2012.01.02422520524]Search in Google Scholar
[142. Cecconi M, Rhodes A, Della Rocca G. From arterial pressures to cardiac output. JL Vincent (ed), 2008 Yearbook of intensive care and emergency medicine. Berlin: Springer Verlag, 2008; p. 591-600.10.1007/978-3-540-77290-3_55]Search in Google Scholar